4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-21-013316
Director sold 30,374 shares at an average $132.37 ($4,020,667)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2021-03-22 | Sale | −3,600 | $129.36 | $465,678 | 57,149 | D |
| Bolzon Bradley J PhD Director | 2021-03-22 | Sale | −3,413 | $130.42 | $445,112 | 53,736 | D |
| Bolzon Bradley J PhD Director | 2021-03-22 | Sale | −2,400 | $131.14 | $314,741 | 51,336 | D |
| Bolzon Bradley J PhD Director | 2021-03-22 | Sale | −6,090 | $132.53 | $807,092 | 45,246 | D |
| Bolzon Bradley J PhD Director | 2021-03-22 | Sale | −9,334 | $133.28 | $1,244,070 | 35,912 | D |
| Bolzon Bradley J PhD Director | 2021-03-22 | Sale | −5,237 | $134.33 | $703,495 | 30,675 | D |
| Bolzon Bradley J PhD Director | 2021-03-22 | Sale | −300 | $134.93 | $40,478 | 30,375 | D |
| Open-market sales · 30,374 sh · avg $132.37 · $4,020,667 | |||||||
Loading xslF345X03/doc4.xml…